RxDoctor Payments Data

May Thomassee, MD

Gynecology · Lafayette, LANPI 1235333725

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (55.6%), education and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Medical Device Business Services, Inc. at 56.5% of the total. Reporting peaked in 2023 at $12,542 and has fallen 61.6% since, to $4,813 in 2025. Among gynecology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$50,372in general payments, 2019–2025

Across 137 payments — averaging $367.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$28K
  • Intuitive Surgical$19K
  • Johnson & Johnson$1K
  • Bayer$1K
  • AbbVie$272
  • Astellas Pharma US Inc$152
  • plus $420 from 10 others

What the payments were for

  • Consulting fees$28,01556%
  • Speaking & faculty fees$5001%
  • Travel & lodging$6,40713%
  • Food & beverage$3,7407%
  • Education$11,67823%
  • Gifts$320%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$50,372 in reported general payments places this provider in the 95th percentile of 37 gynecology providers in Louisiana.

See all gynecology providers in Louisiana

Medicare billing

Part B allowed, 2024
$22,358
Medicare patients
85
Services billed
192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated11$8,321
Estradiol126$8,122
YuvafemEstradiol12$1,574
Estradiol (Twice Weekly)Estradiol15$1,464
ProgesteroneProgesterone, Micronized12$636
Estradiol (Once Weekly)Estradiol12$557
Terconazole17$547
Clobetasol Propionate15$357
Oxybutynin Chloride ErOxybutynin Chloride11$100
Fluconazole17$67
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$30

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$46$8,32111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 37 gynecology providers in Louisiana.

Other gynecology in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →